Upper Gastrointestinal Biopsy
Publication Date: October 1, 2015
Key Points
Key Points
The purpose of the current guideline is to establish evidence-based practicing standards for the performance of biopsies of normal-appearing mucosa in the upper gastrointestinal tract.
Dyspepsia is defined according to the Rome III criteria, which include ≥1 of the following symptoms: bothersome postprandial fullness, early satiation, epigastric pain, and epigastric burning.
The guideline assumes no prior treatment for Helicobacter pylori (HP) infection.
Dyspepsia is defined according to the Rome III criteria, which include ≥1 of the following symptoms: bothersome postprandial fullness, early satiation, epigastric pain, and epigastric burning.
The guideline assumes no prior treatment for Helicobacter pylori (HP) infection.
Diagnosis
...Diagn...
...me III Criteria for Functional Dyspepsia...
...intestinal Biopsy to Evaluate Dyspepsia in the A...
Summary of Recommendations from the AGA Guideline on Upper-GI Biopsies to Evaluate Adult Dyspepsia
...Summary of Re...
...ophagusIn patients undergoing EGD for...
...omachIn immunocompetent patients undergoing...
...immunocompromised patients undergoing E...
...biopsies from the normal-appearing gastric bo...
...opsies are obtained from the normal-appearing gas...
...patients undergoing EGD for dyspepsi...
...omised patients undergoing EGD for...
...re obtained from the normal-appearing duodenum, th...
Locations of Gastric Biopsy Recommended by the Updated Sydney System
...ons of Gastric Biopsy Recommended by...